# Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

> **NCT02911480** · PHASE1 · WITHDRAWN · sponsor: **Oxytone Bioscience BV**

## Conditions studied

- Healthy Women of Child Bearing Potential

## Interventions

- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02911480
- **Lead sponsor:** Oxytone Bioscience BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2017-02
- **Final completion:** 2017-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study/financial issues
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911480, "Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02911480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*